Data / Form D filings / NeuroVive Pharmaceutical AB
NeuroVive Pharmaceutical AB: Form D filing
NeuroVive Pharmaceutical AB, a pharmaceuticals company in 81 Lund, Sweden, filed a Form D with the SEC in 2015. The latest, on May 27, 2015, reports $7.5 million sold of a $25 million offering to 11 investors.
Find out what NeuroVive Pharmaceutical AB does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- MEDICON VILLAGE SE-223, 81 Lund, Sweden, None
- Phone
- +46-46-275 6220
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Sweden
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1643349
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 27, 2015 | New notice | $25,000,000 | $7,462,732 | $17,537,268 | 11 | May 8, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jan Nilsson | Executive Officer | |
| Helmuth Malm Von Moltke | Director | |
| Helena Malm Levander | Director | |
| Catharina Johansson | Executive Officer | |
| Arne Malm Ferstad | Director | |
| Marcus Malm Keep | Director | |
| Carl Fredrick Olsson | Director | |
| Mikael Bronnegard | Executive Officer | |
| Boel Malm Flodgren | Director | |
| Anna Malm Bernsten | Director | |
| Eskil Elmer | Executive Officer | |
| Gregory Batcheller | Executive Officer, Director |
Every Form D from the week of May 25, 2015 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what NeuroVive Pharmaceutical AB reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.